| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,102 |
2,793 |
$5.29M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,753 |
20,515 |
$4.25M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,762 |
10,223 |
$4.25M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,042 |
16,384 |
$1.71M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,771 |
2,478 |
$1.38M |
| 80053 |
Comprehensive metabolic panel |
28,783 |
23,569 |
$1.02M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,379 |
8,632 |
$927K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,538 |
6,368 |
$879K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,504 |
25,972 |
$801K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,441 |
5,950 |
$701K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,304 |
3,414 |
$659K |
| G0378 |
Hospital observation service, per hour |
1,250 |
934 |
$656K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
10,891 |
4,948 |
$653K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,360 |
4,595 |
$651K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,580 |
6,784 |
$642K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,357 |
5,698 |
$527K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,857 |
2,078 |
$493K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
442 |
382 |
$462K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,858 |
11,797 |
$455K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
680 |
591 |
$444K |
| 71045 |
Radiologic examination, chest; single view |
6,505 |
5,473 |
$433K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,602 |
1,545 |
$412K |
| 36415 |
Collection of venous blood by venipuncture |
44,548 |
35,799 |
$411K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,220 |
6,924 |
$381K |
| 80306 |
|
5,316 |
4,630 |
$378K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
506 |
471 |
$366K |
| 71046 |
Radiologic examination, chest; 2 views |
2,933 |
2,707 |
$357K |
| 81001 |
|
16,986 |
14,483 |
$351K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,017 |
3,620 |
$321K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,357 |
6,262 |
$309K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,198 |
3,262 |
$273K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15,775 |
9,595 |
$249K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,984 |
3,599 |
$236K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,284 |
2,100 |
$210K |
| 73030 |
|
1,420 |
1,277 |
$203K |
| 76830 |
Ultrasound, transvaginal |
1,319 |
1,274 |
$182K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,259 |
3,382 |
$173K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,523 |
2,102 |
$171K |
| 80061 |
Lipid panel |
6,541 |
6,326 |
$158K |
| 84484 |
|
6,323 |
4,448 |
$155K |
| 73610 |
|
1,061 |
950 |
$155K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,516 |
1,952 |
$149K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
324 |
285 |
$147K |
| 73630 |
|
1,028 |
937 |
$143K |
| 96376 |
|
2,853 |
1,752 |
$142K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,917 |
1,639 |
$138K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,162 |
1,152 |
$127K |
| 73110 |
|
861 |
719 |
$126K |
| 97162 |
|
1,627 |
1,532 |
$122K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,833 |
1,507 |
$121K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,266 |
4,727 |
$113K |
| 87186 |
|
2,663 |
2,405 |
$109K |
| 73562 |
|
742 |
692 |
$107K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,232 |
734 |
$106K |
| 81025 |
|
4,197 |
3,910 |
$105K |
| 84439 |
|
3,577 |
3,252 |
$104K |
| 82728 |
|
2,830 |
2,730 |
$104K |
| 85027 |
|
4,141 |
3,670 |
$102K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,237 |
4,983 |
$98K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
98 |
91 |
$96K |
| 73130 |
|
645 |
570 |
$95K |
| 85610 |
|
6,490 |
5,024 |
$93K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,654 |
4,880 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,527 |
4,583 |
$92K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,281 |
1,182 |
$89K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,013 |
1,204 |
$89K |
| 84703 |
|
2,675 |
2,517 |
$88K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,226 |
1,119 |
$88K |
| 87071 |
|
3,322 |
3,112 |
$88K |
| 86140 |
|
3,705 |
3,324 |
$88K |
| 85379 |
|
3,390 |
2,935 |
$87K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,853 |
2,747 |
$86K |
| 83880 |
|
3,179 |
2,628 |
$83K |
| 83690 |
|
5,576 |
4,780 |
$82K |
| 97161 |
|
1,249 |
1,158 |
$80K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,192 |
2,281 |
$79K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,230 |
5,954 |
$78K |
| 83605 |
|
6,075 |
4,880 |
$78K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,945 |
1,249 |
$77K |
| 85730 |
|
4,529 |
3,835 |
$73K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,685 |
2,593 |
$72K |
| 82948 |
|
3,819 |
2,100 |
$68K |
| 87040 |
|
2,876 |
1,864 |
$65K |
| 86703 |
|
1,949 |
1,904 |
$61K |
| 82785 |
|
301 |
297 |
$61K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
240 |
235 |
$61K |
| 72100 |
|
362 |
347 |
$60K |
| 83735 |
|
3,937 |
2,921 |
$56K |
| 87507 |
|
263 |
237 |
$54K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
2,875 |
2,642 |
$53K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,904 |
1,826 |
$49K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
59 |
52 |
$48K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,690 |
3,178 |
$46K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,909 |
3,388 |
$46K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
5,096 |
3,353 |
$43K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
170 |
164 |
$43K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,287 |
1,080 |
$42K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
258 |
234 |
$41K |
| J2704 |
Injection, propofol, 10 mg |
2,201 |
1,896 |
$40K |
| 85652 |
|
2,172 |
1,941 |
$39K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
355 |
321 |
$39K |
| 82150 |
|
1,474 |
1,331 |
$38K |
| 87077 |
|
2,934 |
2,657 |
$38K |
| 86885 |
|
1,640 |
1,480 |
$38K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,050 |
1,042 |
$37K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
146 |
93 |
$31K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
197 |
192 |
$31K |
| 73564 |
|
191 |
178 |
$31K |
| 73502 |
|
216 |
195 |
$30K |
| 83540 |
|
1,790 |
1,705 |
$29K |
| 84702 |
|
1,232 |
886 |
$28K |
| 86803 |
|
1,416 |
1,382 |
$26K |
| 74018 |
|
218 |
206 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,362 |
756 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
758 |
681 |
$25K |
| 97113 |
|
297 |
127 |
$25K |
| 83550 |
|
1,478 |
1,402 |
$24K |
| 90715 |
|
244 |
228 |
$24K |
| 82607 |
|
820 |
785 |
$23K |
| J2060 |
Injection, lorazepam, 2 mg |
1,694 |
1,378 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
335 |
302 |
$23K |
| 86900 |
|
1,959 |
1,630 |
$23K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,451 |
1,201 |
$22K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,959 |
1,905 |
$21K |
| 86901 |
|
1,797 |
1,515 |
$21K |
| 80143 |
|
515 |
436 |
$20K |
| 76801 |
|
132 |
123 |
$20K |
| 86780 |
|
1,480 |
1,450 |
$20K |
| 82570 |
|
1,308 |
1,204 |
$20K |
| 80179 |
|
460 |
391 |
$19K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
225 |
214 |
$19K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
27 |
25 |
$19K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,804 |
1,667 |
$19K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
12 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,066 |
836 |
$17K |
| 0240U |
|
2,459 |
2,146 |
$17K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,377 |
1,260 |
$17K |
| 87340 |
|
969 |
933 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
177 |
162 |
$16K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
85 |
79 |
$16K |
| 81003 |
|
941 |
823 |
$15K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
71 |
69 |
$15K |
| 86701 |
|
529 |
506 |
$14K |
| 76642 |
|
94 |
88 |
$12K |
| 82043 |
|
841 |
797 |
$12K |
| 80076 |
|
464 |
432 |
$12K |
| 86003 |
|
328 |
323 |
$12K |
| 87205 |
|
945 |
849 |
$11K |
| 84100 |
|
721 |
471 |
$10K |
| 59025 |
Fetal non-stress test |
56 |
27 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
612 |
471 |
$9K |
| 86592 |
|
471 |
453 |
$9K |
| 94060 |
|
57 |
57 |
$8K |
| 82803 |
|
165 |
127 |
$8K |
| 84466 |
|
214 |
211 |
$8K |
| 73140 |
|
68 |
65 |
$7K |
| 72040 |
|
37 |
37 |
$7K |
| 97165 |
|
137 |
126 |
$7K |
| 96367 |
|
182 |
127 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
12 |
$6K |
| 84145 |
|
138 |
115 |
$6K |
| 86762 |
|
330 |
321 |
$6K |
| 93971 |
|
78 |
69 |
$5K |
| 82947 |
|
229 |
220 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
276 |
253 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
61 |
12 |
$5K |
| 99215 |
Prolong outpt/office vis |
50 |
40 |
$5K |
| 82950 |
|
126 |
122 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
556 |
440 |
$4K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
61 |
49 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
107 |
93 |
$4K |
| 87210 |
|
217 |
210 |
$4K |
| 81015 |
|
407 |
382 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
171 |
93 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
252 |
210 |
$4K |
| 87420 |
|
89 |
87 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
28 |
27 |
$3K |
| 86038 |
|
143 |
137 |
$3K |
| J3490 |
Unclassified drugs |
1,459 |
945 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
145 |
135 |
$3K |
| 84403 |
|
124 |
123 |
$3K |
| 73080 |
|
26 |
24 |
$3K |
| 86787 |
|
193 |
190 |
$3K |
| 99152 |
|
350 |
343 |
$3K |
| 76770 |
|
12 |
12 |
$3K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
39 |
28 |
$3K |
| 87081 |
|
80 |
78 |
$3K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
380 |
259 |
$3K |
| 76857 |
|
15 |
14 |
$3K |
| 82784 |
|
57 |
53 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
86 |
83 |
$2K |
| 80047 |
|
103 |
91 |
$2K |
| 74019 |
|
13 |
13 |
$2K |
| 83655 |
|
132 |
128 |
$2K |
| 73590 |
|
13 |
13 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
109 |
39 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
270 |
218 |
$2K |
| 87088 |
|
106 |
97 |
$2K |
| 94729 |
|
25 |
25 |
$2K |
| 12001 |
|
16 |
14 |
$1K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
90 |
88 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,138 |
1,025 |
$1K |
| 87486 |
|
85 |
79 |
$1K |
| 82550 |
|
76 |
64 |
$1K |
| 87581 |
|
85 |
79 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
143 |
126 |
$1K |
| 73010 |
|
12 |
12 |
$1K |
| 86704 |
|
24 |
23 |
$1K |
| A9270 |
Non-covered item or service |
6,937 |
1,334 |
$1K |
| 73560 |
|
16 |
12 |
$1K |
| 84550 |
|
56 |
53 |
$936.44 |
| 86999 |
|
87 |
81 |
$809.54 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
137 |
103 |
$800.22 |
| 0352U |
|
341 |
334 |
$766.16 |
| 85014 |
|
114 |
102 |
$761.15 |
| 85007 |
|
229 |
204 |
$747.44 |
| 97803 |
|
16 |
12 |
$706.41 |
| 86308 |
|
28 |
28 |
$688.38 |
| 86695 |
|
43 |
39 |
$650.02 |
| J1644 |
Injection, heparin sodium, per 1000 units |
83 |
38 |
$604.88 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
12 |
12 |
$571.67 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
16 |
15 |
$552.67 |
| 36000 |
|
12 |
12 |
$543.52 |
| 80178 |
|
32 |
25 |
$526.64 |
| J7050 |
Infusion, normal saline solution, 250 cc |
28 |
12 |
$514.09 |
| 84146 |
|
28 |
26 |
$509.95 |
| 83516 |
|
17 |
16 |
$499.45 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
51 |
43 |
$467.78 |
| 94726 |
|
13 |
13 |
$465.16 |
| 86696 |
|
30 |
26 |
$453.89 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
19 |
12 |
$414.43 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
94 |
88 |
$395.59 |
| C9113 |
Injection, pantoprazole sodium, per vial |
26 |
16 |
$386.72 |
| 97535 |
Self-care/home management training, each 15 minutes |
16 |
16 |
$367.24 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
386 |
307 |
$359.26 |
| 82746 |
|
14 |
13 |
$324.38 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
28 |
28 |
$311.21 |
| J1630 |
Injection, haloperidol, up to 5 mg |
28 |
26 |
$299.53 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
181 |
141 |
$297.27 |
| 84480 |
|
15 |
15 |
$261.94 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
20 |
19 |
$261.20 |
| 82274 |
|
15 |
14 |
$217.63 |
| 97116 |
|
17 |
12 |
$204.48 |
| 86480 |
|
12 |
12 |
$178.49 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
24 |
24 |
$170.12 |
| 87150 |
|
136 |
127 |
$152.29 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
17 |
13 |
$111.99 |
| 85008 |
|
231 |
205 |
$104.33 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
17 |
15 |
$98.61 |
| 80320 |
|
1,162 |
981 |
$77.08 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,391 |
1,637 |
$8.35 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
36 |
33 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
69 |
59 |
$0.00 |